rejuvant life tabs

Going deeper on ketone analysis for longevity

Latest articles

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...
Rejuvant

BIOSENSE CEO shares how deep lung samples deliver a better measure of ketosis and fat metabolism.

Linked with several longevity benefits, ketosis is a metabolic state in which your body uses fat and ketones rather than glucose as its main fuel source. In addition to helping you burn fat, ketosis can make you feel less hungry, and can also help you maintain muscle: a hugely important factor in aging well and longevity.

When it comes to measuring ketone levels in our breath, St Louis-based company Readout Health claims to have the only “clinically backed” product on the market. The company’s BIOSENSE breathalyser product uses a deep lung sampling process that provides a full daily picture of the depth and duration of an individual’s ketosis, and provides an accurate measure of their fat metabolism rate. BIOSENSE corrects for natural variations in our exhalation time and lung capacity, which the company says provides “more accurate and reproducible measurements.”

Longevity.Technology: Achieving and staying in ketosis isn’t easy, so tools that can tell you when you’re actually in the zone are useful. With its patented ketone breathalyser, BIOSENSE is positioning itself at the forefront of ketone measurement in terms of accuracy. Ahead of our product review, which you can read here, we caught up with the company’s president and CEO Jim Howard.    

A 27-year health tech veteran, Howard was all too aware of the technology gaps that exist when it comes to non-invasive home testing. For health reasons, he and his wife had adopted a ketogenic lifestyle and were using a finger prick test to track their ketone levels.

Biosense CEO shares how deep lung samples deliver a better measure of ketosis and fat metabolism.

“We were pricking our fingers every day, but I knew from my respiratory diagnostic days that ketones, like glucose, go up and down,” says Howard. “So checking it once a day doesn’t really mean that much. It’s good to know, but it only tells you what your level was in the last two hours.”

 


 

“ … these guys had apparently cracked the code on lung sampling.”

 


 

After exiting a previous company, Howard was looking for something new when he found out about some new technology being developed that intrigued him.

“I heard that there was a project happening on the West Coast, where these guys had apparently cracked the code on lung sampling,” he explains.

The “guys” Howard had heard about were twin brothers Tim and Matt Ratto, who were working on a clinical-grade breath analysis solution for Type-1 diabetic children. The solution was intended to allow parents to non-invasively monitor for diabetic ketoacidosis (DKA), a life-threatening problem that affects people with diabetes.

Biosense CEO shares how deep lung samples deliver a better measure of ketosis and fat metabolism.

“They were in the process of patenting this deep lung sampling technique,” says Howard. “This is different because, when you blow in to this device, most of your air goes out the side, and then a pump kicks in, and it takes a tiny sample of your end-of-breath into a closed flow cell. And that’s where the ketones are super concentrated.”

Shortly after meeting with the brothers, Howard came on board along with some investment, and the company was formed in 2018.

Elevant

“We are a fast-moving company – we finished the development within a year and we launched in January 2020,” he says. “The first 2,000 devices we put on the market were mainly to get measurements so we could build out our machine learning capabilities, and then get feedback on the firmware.”

 


 

“This is a medical device and we have lots of clinical trials that we’re part of right now, and they need to have highly accurate measurements.”

 


 

Howard estimates that the software on the device has probably gone through around 26 upgrades since launch.

“That’s really important for the clinical community,” explains Howard. “This is a medical device and we have lots of clinical trials that we’re part of right now, and they need to have highly accurate measurements. So we have a full range from zero to 40 ACEs, whereas if you don’t have deep lung sampling, you’re limited to four or five ranges, and that doesn’t work in clinical environments.”

The ACEs that Howard refers to is a unit that translates parts per million (ppm) of breath acetone into a blood ketone equivalent. This enables BIOSENSE to determine your exact ketone level on a scale from 0-40 but also where you are on the broader spectrum of ketosis:

“We just did an internal study on fasting and autophagy and, based on clinical studies, we’ve inferred that about 15 is the average level of ACEs at which you’re entering autophagy,” says Howard. “People claim that an 18:6 fasting regime puts you in autophagy, but you’re nowhere near it. Our internal study showed that it ranges from six to 60 hours to get into an inferred state of autophagy. This is the sort of thing that we’re debunking.”

 


 

“We’ve built a clinical grade product that consumers can use too, but it’s typically going to be your more knowledgeable consumer.”

 


 

While BIOSENSE is designed for clinical use, the company is also finding a market in the consumer space.

“We’ve built a clinical grade product that consumers can use too, but it’s typically going to be your more knowledgeable consumer,” says Howard. “A consumer that understands the difference between backed by science versus backed by a clinical trial.”

The trial he’s referring to is this study, which demonstrated a close correlation between breath-based readings generated by BIOSENSE and blood-based measurements.

Elevant

“The other thing we showed in that study was something we had all assumed, which is that ketones are highly variable,” says Howards. “If you do one measurement a day, you are more than 50% off your time-weighted average. So why are we all just relying on a once a day measurements?”

Images courtesy of Biosense

Comment on this article

Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...

BioAge licenses Amgen drug to treat muscle aging

Exclusive deal to develop and commercialise Amgen’s Phase 1 APJ agonist, after BioAge platform identifies its potential in promoting longevity and reducing symptoms of...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...
Supps report ad middle